Royce & Associates’s Abeona Therapeutics ABEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-5,689
| Closed | -$223K | – | 1014 |
|
|
2020
Q4 | $223K | Hold |
5,689
| – | – | ﹤0.01% | 956 |
|
|
2020
Q3 | $145K | Hold |
5,689
| – | – | ﹤0.01% | 952 |
|
|
2020
Q2 | $415K | Hold |
5,689
| – | – | ﹤0.01% | 878 |
|
|
2020
Q1 | $299K | Hold |
5,689
| – | – | ﹤0.01% | 885 |
|
|
2019
Q4 | $465K | Hold |
5,689
| – | – | ﹤0.01% | 896 |
|
|
2019
Q3 | $321K | Hold |
5,689
| – | – | ﹤0.01% | 943 |
|
|
2019
Q2 | $680K | Hold |
5,689
| – | – | 0.01% | 872 |
|
|
2019
Q1 | $1.05M | Hold |
5,689
| – | – | 0.01% | 853 |
|
|
2018
Q4 | $1.02M | Hold |
5,689
| – | – | 0.01% | 855 |
|
|
2018
Q3 | $1.82M | Hold |
5,689
| – | – | 0.01% | 846 |
|
|
2018
Q2 | $2.28M | Hold |
5,689
| – | – | 0.02% | 807 |
|
|
2018
Q1 | $2.04M | Hold |
5,689
| – | – | 0.01% | 846 |
|
|
2017
Q4 | $2.25M | Sell |
5,689
-3,400
| -37% | -$1.35M | 0.02% | 819 |
|
|
2017
Q3 | $3.87M | Sell |
9,089
-3,400
| -27% | -$1.45M | 0.03% | 651 |
|
|
2017
Q2 | $2M | Hold |
12,489
| – | – | 0.01% | 840 |
|
|
2017
Q1 | $1.56M | Hold |
12,489
| – | – | 0.01% | 915 |
|
|
2016
Q4 | $1.51M | Sell |
12,489
-2,504
| -17% | -$304K | 0.01% | 875 |
|
|
2016
Q3 | $2.25M | Sell |
14,993
-60
| -0.4% | -$9K | 0.01% | 771 |
|
|
2016
Q2 | $888K | Hold |
15,053
| – | – | 0.01% | 932 |
|
|
2016
Q1 | $963K | Buy |
15,053
+3,067
| +26% | +$196K | 0.01% | 933 |
|
|
2015
Q4 | $1.01M | Buy |
11,986
+9,699
| +424% | +$815K | 0.01% | 934 |
|
|
2015
Q3 | $232K | Buy |
+2,287
| New | +$232K | ﹤0.01% | 1097 |
|